Cargando…

Cognitive performance in systemic lupus erythematosus patients: a cross-sectional and longitudinal study

BACKGROUND: Previous research has provided evidence for cognitive dysfunction as a common symptom of systemic lupus erythematosus (SLE). In light of this, the primary goal of this study was to investigate how cognitive impairment in this patient group develops over time. In addition, the present dat...

Descripción completa

Detalles Bibliográficos
Autores principales: Langensee, L., Mårtensson, J., Jönsen, A., Zervides, K., Bengtsson, A., Nystedt, J., Cannerfelt, B., Nilsson, P., Mannfolk, P., Lätt, J., Rumetshofer, T., Sundgren, P. C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9019974/
https://www.ncbi.nlm.nih.gov/pubmed/35440096
http://dx.doi.org/10.1186/s41927-022-00253-3
_version_ 1784689422623571968
author Langensee, L.
Mårtensson, J.
Jönsen, A.
Zervides, K.
Bengtsson, A.
Nystedt, J.
Cannerfelt, B.
Nilsson, P.
Mannfolk, P.
Lätt, J.
Rumetshofer, T.
Sundgren, P. C.
author_facet Langensee, L.
Mårtensson, J.
Jönsen, A.
Zervides, K.
Bengtsson, A.
Nystedt, J.
Cannerfelt, B.
Nilsson, P.
Mannfolk, P.
Lätt, J.
Rumetshofer, T.
Sundgren, P. C.
author_sort Langensee, L.
collection PubMed
description BACKGROUND: Previous research has provided evidence for cognitive dysfunction as a common symptom of systemic lupus erythematosus (SLE). In light of this, the primary goal of this study was to investigate how cognitive impairment in this patient group develops over time. In addition, the present dataset contributes to delineating the specific abilities that are impaired in SLE patients as well as answering the question whether the disease affects the cognition of SLE patients with neuropsychiatric manifestations (NPSLE) and without (non-NPSLE) in distinct ways. METHODS: 91 female participants (33 NPSLE, 29 non-NPSLE, 29 healthy controls (HC)) underwent standardized neurocognitive testing. A total of ten different cognitive abilities were assessed, among others executive function, memory, and attention. Some of the participants (30 NPSLE patients, 22 non-NPSLE, 13 HC) were tested twice (mean time between testing sessions: 50 months) to enable longitudinal tracking of cognitive abilities. Analyses of Variance (ANOVA) were conducted to determine whether cognitive performance differed cross-sectionally between the groups. Linear mixed effects models were fit to investigate performance differences between the groups over time. RESULTS: Cross-sectional analysis at follow-up demonstrated that the cognitive performance of both NPSLE and non-NPSLE was significantly lower than that of HC for the motor speed and the psychomotor speed domain. Additionally, NPSLE patients performed significantly weaker than HC in the complex attention domain. At the same time, the cross-sectional data did not yield any support for performance differences between NPSLE and non-NPSLE patients. Weak positive correlations between disease duration and psychomotor speed, motor speed and reaction time emerged. A temporal progression of cognitive dysfunction in SLE patients was not confirmed. CONCLUSIONS: Cognitive performance is affected in both non-NPSLE and NPSLE patients. However, a linear decline in performance over time could not be verified. More in-depth longitudinal assessments of cognition in SLE patients are needed to establish how cognitive abilities in this patient population develop over time. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s41927-022-00253-3.
format Online
Article
Text
id pubmed-9019974
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-90199742022-04-21 Cognitive performance in systemic lupus erythematosus patients: a cross-sectional and longitudinal study Langensee, L. Mårtensson, J. Jönsen, A. Zervides, K. Bengtsson, A. Nystedt, J. Cannerfelt, B. Nilsson, P. Mannfolk, P. Lätt, J. Rumetshofer, T. Sundgren, P. C. BMC Rheumatol Research BACKGROUND: Previous research has provided evidence for cognitive dysfunction as a common symptom of systemic lupus erythematosus (SLE). In light of this, the primary goal of this study was to investigate how cognitive impairment in this patient group develops over time. In addition, the present dataset contributes to delineating the specific abilities that are impaired in SLE patients as well as answering the question whether the disease affects the cognition of SLE patients with neuropsychiatric manifestations (NPSLE) and without (non-NPSLE) in distinct ways. METHODS: 91 female participants (33 NPSLE, 29 non-NPSLE, 29 healthy controls (HC)) underwent standardized neurocognitive testing. A total of ten different cognitive abilities were assessed, among others executive function, memory, and attention. Some of the participants (30 NPSLE patients, 22 non-NPSLE, 13 HC) were tested twice (mean time between testing sessions: 50 months) to enable longitudinal tracking of cognitive abilities. Analyses of Variance (ANOVA) were conducted to determine whether cognitive performance differed cross-sectionally between the groups. Linear mixed effects models were fit to investigate performance differences between the groups over time. RESULTS: Cross-sectional analysis at follow-up demonstrated that the cognitive performance of both NPSLE and non-NPSLE was significantly lower than that of HC for the motor speed and the psychomotor speed domain. Additionally, NPSLE patients performed significantly weaker than HC in the complex attention domain. At the same time, the cross-sectional data did not yield any support for performance differences between NPSLE and non-NPSLE patients. Weak positive correlations between disease duration and psychomotor speed, motor speed and reaction time emerged. A temporal progression of cognitive dysfunction in SLE patients was not confirmed. CONCLUSIONS: Cognitive performance is affected in both non-NPSLE and NPSLE patients. However, a linear decline in performance over time could not be verified. More in-depth longitudinal assessments of cognition in SLE patients are needed to establish how cognitive abilities in this patient population develop over time. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s41927-022-00253-3. BioMed Central 2022-04-20 /pmc/articles/PMC9019974/ /pubmed/35440096 http://dx.doi.org/10.1186/s41927-022-00253-3 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Langensee, L.
Mårtensson, J.
Jönsen, A.
Zervides, K.
Bengtsson, A.
Nystedt, J.
Cannerfelt, B.
Nilsson, P.
Mannfolk, P.
Lätt, J.
Rumetshofer, T.
Sundgren, P. C.
Cognitive performance in systemic lupus erythematosus patients: a cross-sectional and longitudinal study
title Cognitive performance in systemic lupus erythematosus patients: a cross-sectional and longitudinal study
title_full Cognitive performance in systemic lupus erythematosus patients: a cross-sectional and longitudinal study
title_fullStr Cognitive performance in systemic lupus erythematosus patients: a cross-sectional and longitudinal study
title_full_unstemmed Cognitive performance in systemic lupus erythematosus patients: a cross-sectional and longitudinal study
title_short Cognitive performance in systemic lupus erythematosus patients: a cross-sectional and longitudinal study
title_sort cognitive performance in systemic lupus erythematosus patients: a cross-sectional and longitudinal study
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9019974/
https://www.ncbi.nlm.nih.gov/pubmed/35440096
http://dx.doi.org/10.1186/s41927-022-00253-3
work_keys_str_mv AT langenseel cognitiveperformanceinsystemiclupuserythematosuspatientsacrosssectionalandlongitudinalstudy
AT martenssonj cognitiveperformanceinsystemiclupuserythematosuspatientsacrosssectionalandlongitudinalstudy
AT jonsena cognitiveperformanceinsystemiclupuserythematosuspatientsacrosssectionalandlongitudinalstudy
AT zervidesk cognitiveperformanceinsystemiclupuserythematosuspatientsacrosssectionalandlongitudinalstudy
AT bengtssona cognitiveperformanceinsystemiclupuserythematosuspatientsacrosssectionalandlongitudinalstudy
AT nystedtj cognitiveperformanceinsystemiclupuserythematosuspatientsacrosssectionalandlongitudinalstudy
AT cannerfeltb cognitiveperformanceinsystemiclupuserythematosuspatientsacrosssectionalandlongitudinalstudy
AT nilssonp cognitiveperformanceinsystemiclupuserythematosuspatientsacrosssectionalandlongitudinalstudy
AT mannfolkp cognitiveperformanceinsystemiclupuserythematosuspatientsacrosssectionalandlongitudinalstudy
AT lattj cognitiveperformanceinsystemiclupuserythematosuspatientsacrosssectionalandlongitudinalstudy
AT rumetshofert cognitiveperformanceinsystemiclupuserythematosuspatientsacrosssectionalandlongitudinalstudy
AT sundgrenpc cognitiveperformanceinsystemiclupuserythematosuspatientsacrosssectionalandlongitudinalstudy